Setting a New Standard in Treating Oral Mucositis

Beyond Prevention: A Curative Vision

For patients undergoing cancer treatment, Oral Mucositis (OM) isn't just a side effect, it’s a debilitating barrier to recovery. At Oralight, we are bridging the gap between breakthrough science and bedside reality.

The Science of Light, Perfected

Looking Ahead

In collaboration with a world-leading institutional partner, we plan to open a pilot clinical study in 2026 to validate this combination approach. Our goal is simple: to ensure that no patient has to choose between life-saving treatment and their quality of life.

Our light-based therapy utilizes a novel, patented light applicator device that enables automated, precise administration for maximum effectiveness that is easy, fast, with no patient discomfort.

We set a new standard for Photobiomodulation (PBM) in treating patients with OM... yet we go beyond prophylactic PBM to add antimicrobial photodynamic therapy (PDT) to present a curative breakthrough therapy for treating all patients at all stages of OM.